Dede Willams

Pemex Loses Bid to Recover Stolen Gas

American Chemistry Council Launches pro-BPA Campaign

Arrowhead Buys Novartis’ RNAi R&D Portfolio

BASF Expanding Specialty Amines Output at Ludwigshafen

Axalta Building New Waterborne Coatings Plant in China

AbbVie to Acquire Pharmacyclics for $21 Billion

Arkema Acquires Italian Peroxide Producer Oxido

DuPont Rejects Activist Investor’s Universal Ballot Request

Wacker Builds New Specialty Monomers Plant in Burghausen

AstraZeneca Buy of Actavis’ Respiratory Products Complete

US Extends List of Climate-Friendly Refrigerants

New Sanofi Chief’s “Welcome Bonus” Slammed

Actavis Hormonal IUD Wins FDA Approval

Bayer MaterialScience Buys Composites Specialist

BASF and Toda Kogyo Agree JV on Cathode Materials for Batteries

RWE Poised to Sell DEA Arm to Russian Tycoon

Baumann Says He’ll Fight to Keep Bayer Independent

US House Restricts EPA's Scientific Advisory Board

Novartis Gets Green Light to Buy GSK Cancer Drugs

Bayer's Carve-Out of MaterialScience on Track for 2016

Chevron Quits Shale Gas Market in Romania, too

Funds Advised by Apax Partners to Acquire Azelis From 3i

German Chemical Industry Sees Weak Close to 2014

Richard Pott Picked to Chair Bayer MaterialScience Supervisory Board

Activist hedge funds' Assets Swell Six-fold in ten Years

Solvay to Build New Plant for PEEK Resins in US

Karyn Ovelmen to Step Down as LyondellBasell CFO

China Mulling Mergers Among State Oil Companies?

Sanofi and Lead Pharma Seal Autoimmune R&D Pact

FDA Eases Path to Genetic Disease Screening

Yara and BASF Building Ammonia Plant in Texas

Avella to Distribute Bayer’s Nexavar and Stivarga in US

Merck & Co Analyst Pleads Guilty to Insider Trading

Lanxess to Maintain Dividend at 50 Cents

Bayer’s Brandicourt Could Be New Sanofi CEO

754 more articles

Top-Feature

BIO Deutschland e.V.

German Biotech Days 2026: Biotechnology as The Key to Industrial Competitiveness

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Interview

Navigating Uncertainty and Driving Innovation

Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing